Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Relation of cumulative low-level lead exposure to depressive and phobic anxiety symptom scores in middle-age and elderly women.

Eum KD, Korrick SA, Weuve J, Okereke O, Kubzansky LD, Hu H, Weisskopf MG.

Environ Health Perspect. 2012 Jun;120(6):817-23. doi: 10.1289/ehp.1104395. Epub 2012 Feb 29.

2.

Cumulative lead exposure and age at menopause in the Nurses' Health Study cohort.

Eum KD, Weisskopf MG, Nie LH, Hu H, Korrick SA.

Environ Health Perspect. 2014 Mar;122(3):229-34. doi: 10.1289/ehp.1206399. Epub 2014 Jan 7.

3.

Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.

Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I.

Circulation. 2005 Feb 1;111(4):480-7.

4.

Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women.

Farvid MS, Qi L, Hu FB, Kawachi I, Okereke OI, Kubzansky LD, Willett WC.

Brain Behav Immun. 2014 Feb;36:176-82. doi: 10.1016/j.bbi.2013.10.025. Epub 2013 Oct 31.

5.

Cumulative exposure to lead in relation to cognitive function in older women.

Weuve J, Korrick SA, Weisskopf MG, Ryan LM, Schwartz J, Nie H, Grodstein F, Hu H.

Environ Health Perspect. 2009 Apr;117(4):574-80. doi: 10.1289/ehp.11846. Epub 2008 Dec 11. Erratum in: Environ Health Perspect. 2009 Jun;117(6):A238. Weisskopf, Marc A [corrected to Weisskopf, Marc G].

6.

Cumulative lead exposure is associated with reduced olfactory recognition performance in elderly men: The Normative Aging Study.

Grashow R, Sparrow D, Hu H, Weisskopf MG.

Neurotoxicology. 2015 Jul;49:158-64. doi: 10.1016/j.neuro.2015.06.006. Epub 2015 Jun 26.

7.

Association of cumulative lead exposure with Parkinson's disease.

Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, Hersh B, Schwartz J, Wright RO, Hu H.

Environ Health Perspect. 2010 Nov;118(11):1609-13. doi: 10.1289/ehp.1002339.

8.

Cumulative lead exposure in community-dwelling adults and fine motor function: comparing standard and novel tasks in the VA normative aging study.

Grashow R, Spiro A, Taylor KM, Newton K, Shrairman R, Landau A, Sparrow D, Hu H, Weisskopf M.

Neurotoxicology. 2013 Mar;35:154-61. doi: 10.1016/j.neuro.2013.01.005. Epub 2013 Jan 28.

9.

Prospective cohort study of lead exposure and electrocardiographic conduction disturbances in the Department of Veterans Affairs Normative Aging Study.

Eum KD, Nie LH, Schwartz J, Vokonas PS, Sparrow D, Hu H, Weisskopf MG.

Environ Health Perspect. 2011 Jul;119(7):940-4. doi: 10.1289/ehp.1003279. Epub 2011 Mar 17.

10.

Environmental lead exposure and cognitive function in community-dwelling older adults.

Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, Schwartz BS.

Neurology. 2006 Nov 14;67(9):1556-62. Epub 2006 Sep 13.

PMID:
16971698
11.

Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease.

Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB Jr, Sketch MH Jr.

Psychosom Med. 2006 Sep-Oct;68(5):651-6.

PMID:
17012517
12.

Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale.

Sierra B, Hidalgo LA, Chedraui PA.

Maturitas. 2005 Jul 16;51(3):236-45.

PMID:
15978967
13.

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.

Cancer. 2002 Dec 15;95(12):2455-64.

14.

Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study).

Cheng Y, Schwartz J, Vokonas PS, Weiss ST, Aro A, Hu H.

Am J Cardiol. 1998 Sep 1;82(5):594-9.

PMID:
9732886
15.

Diet quality and related factors among Spanish female participants in breast cancer screening programs.

García-Arenzana N, Navarrete-Muñoz EM, Peris M, Salas D, Ascunce N, Gonzalez I, Sánchez-Contador C, Santamariña C, Moreo P, Moreno MP, Carrete JA, Collado-García F, Pedraz-Pingarrón C, Ederra M, Miranda-García J, Vidal C, Aragonés N, Pérez-Gómez B, Vioque J, Pollán M.

Menopause. 2012 Oct;19(10):1121-9.

PMID:
22760085
16.

Performance of polygenic scores for predicting phobic anxiety.

Walter S, Glymour MM, Koenen K, Liang L, Tchetgen Tchetgen EJ, Cornelis M, Chang SC, Rimm E, Kawachi I, Kubzansky LD.

PLoS One. 2013 Nov 20;8(11):e80326. doi: 10.1371/journal.pone.0080326. eCollection 2013.

17.

Phobic anxiety and cognitive performance over 4 years among community-dwelling older women in the Nurses' Health Study.

Okereke OI, Grodstein F.

Am J Geriatr Psychiatry. 2013 Nov;21(11):1125-34. doi: 10.1016/j.jagp.2013.01.050. Epub 2013 Feb 6.

18.

Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.

Seritan AL, Iosif AM, Park JH, DeatherageHand D, Sweet RL, Gold EB.

Menopause. 2010 Mar;17(2):410-5. doi: 10.1097/gme.0b013e3181bf5a62.

PMID:
20216277
19.

Correlates of bone and blood lead levels among middle-aged and elderly women.

Korrick SA, Schwartz J, Tsaih SW, Hunter DJ, Aro A, Rosner B, Speizer FE, Hu H.

Am J Epidemiol. 2002 Aug 15;156(4):335-43.

PMID:
12181103
20.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024

Supplemental Content

Support Center